Janus Henderson Group
DRUG

Janus Henderson Group’s Bright Minds Biosciences DRUG Stock Holding History

Janus Henderson Group’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$93.5M Buy
1,284,324
+128,329
+11% +$10.3M 0.04% 293
2025
Q4 		$90.8M Buy
1,155,995
+10,335
+0.9% +$691K 0.04% 305
2025
Q3 		$69.1M Hold
1,145,660
– – 0.03% 351
2025
Q2 		$30.2M Buy
1,145,660
+34,292
+3% +$1.03M 0.01% 492
2025
Q1 		$40.3M Buy
1,111,368
+602,592
+118% +$22.1M 0.02% 425
2024
Q4 		$18.4M Buy
+508,776
New +$17.9M 0.01% 599

Other funds holding DRUG

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Janus Henderson Group's DRUG Position: Q1 2026 in Review

Janus Henderson Group increased its Bright Minds Biosciences (DRUG) stake by 11% in Q1 2026, buying an estimated $10.3M and bringing the position to 1,284,324 shares worth $93.5M. The position accounts for 0.04% of the portfolio, ranked #293.

Janus Henderson Group first reported a position in DRUG in Q4 2024 and has held it in 6 quarters since. 94 funds tracked by Wall St. Rank hold DRUG as of Q1 2026.

  • Janus Henderson Group held 1,284,324 shares of Bright Minds Biosciences worth $93.5M as of Q1 2026.
  • Janus Henderson Group bought 128,329 Bright Minds Biosciences shares in Q1 2026, an estimated $10.3M.
  • Bright Minds Biosciences made up 0.04% of Janus Henderson Group's portfolio in Q1 2026, its #293 holding.
  • Janus Henderson Group first reported a position in Bright Minds Biosciences in Q4 2024 and has held it in 6 quarters since.
  • 94 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.